VIDEX EC Drug Patent Profile
✉ Email this page to a colleague
When do Videx Ec patents expire, and when can generic versions of Videx Ec launch?
Videx Ec is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in VIDEX EC is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VIDEX EC?
- What are the global sales for VIDEX EC?
- What is Average Wholesale Price for VIDEX EC?
Summary for VIDEX EC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 124 |
Patent Applications: | 5,251 |
Drug Prices: | Drug price information for VIDEX EC |
What excipients (inactive ingredients) are in VIDEX EC? | VIDEX EC excipients list |
DailyMed Link: | VIDEX EC at DailyMed |
Paragraph IV (Patent) Challenges for VIDEX EC
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VIDEX EC | Delayed-release Capsules | didanosine | 200 mg, 250 mg and 400 mg | 021183 | 1 | 2004-06-01 |
US Patents and Regulatory Information for VIDEX EC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-001 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-004 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-002 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-003 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIDEX EC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-001 | Oct 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-002 | Oct 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-003 | Oct 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-004 | Oct 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-004 | Oct 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIDEX EC
See the table below for patents covering VIDEX EC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 217185 | ALLEVIATING CYTOPATHIC EFFECTS OF HTLV-III VIRUS ON CELLS; PHARMACEUTICAL COMPOSITION | ⤷ Sign Up |
Netherlands | 940005 | ⤷ Sign Up | |
Ireland | 64518 | Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxyinosine 2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine | ⤷ Sign Up |
Ireland | 862265 | ⤷ Sign Up | |
Australia | 6196886 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VIDEX EC
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0216510 | SZ 54/1994 | Austria | ⤷ Sign Up | PRODUCT NAME: 2',3'-DIDEOXYINOSIN |
0216510 | 94C0006 | Belgium | ⤷ Sign Up | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
0285237 | 94C0006 | France | ⤷ Sign Up | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
0216510 | SPC/GB94/005 | United Kingdom | ⤷ Sign Up | SPC/GB94/005:, EXPIRES: 20070504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |